Lycoramine hydrobromide is primarily used in research related to its potential therapeutic effects on the central nervous system. It has been studied for its ability to inhibit acetylcholinesterase, an enzyme that breaks down the neurotransmitter acetylcholine. This property makes it a candidate for investigating treatments for neurodegenerative disorders such as Alzheimer's disease, where increasing acetylcholine levels in the brain can help improve cognitive function. Additionally, it has been explored for its neuroprotective effects, which may aid in reducing neuronal damage caused by oxidative stress or other pathological conditions. Research also suggests its potential application in studying mechanisms of memory enhancement and learning processes.